MRNA Rule of 40
Rule of 40 combines revenue growth and free cash flow margin in one quarterly score.
Latest Rule of 40: -386 (2026Q2); +304 pts YoY.
Across the 8 quarters from 2024Q3 to 2026Q2, Rule of 40 ranged from -1104 in 2025Q1 to +102 in 2025Q4.
MRNA Rule of 40
Latest: -386 (2026Q2)
Healthcare Comparison
1 / 3
Other MRNA Charts
More quarter-by-quarter fundamentals for Moderna, Inc.
1 / 6
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
Cumulative FCF